Strong health systems for all with better public spending

1. At a Glance

• Core issue: Low- and middle-income countries (LMICs) spend roughly half the minimum benchmark on per-capita public health under universal health coverage (UHC), and this gap is widening in per-capita terms even as it narrows as a share of GDP [3].
• Trigger: Steep 2025 cuts in foreign aid (led by the US) plus fiscally constrained domestic budgets are forcing a shift in discourse from "more money" to "spend money better" [3].
• UPSC relevance: tests health financing architecture (NHP 2017 targets, National Health Accounts), global health governance (WHO, OECD/DAC aid data), and GS-II/III governance-of-public-spending themes.

2. Why in the News

• In early 2025, the United States — historically contributing over one-third of global Development Assistance for Health (DAH) — announced 67% cuts to its foreign assistance programme [3].
• The UK, France, and Germany followed with cuts of 39%, 35%, and 12% respectively to aid budgets [3].
• OECD (June 2025) projects net ODA to fall 9–17% in 2025, after a 9% fall in 2024 — the first time France, Germany, UK and US would all have cut ODA for two consecutive years [2].
• Bilateral ODA for health specifically is projected to decline 19–33% in 2025 versus 2023 levels; health funding could fall up to 60% from its 2022 pandemic-era peak [2].
• WHO separately projected up to a 40% cut in health aid in 2025 [2].

3. Background & Evolution

• Development Assistance for Health (DAH) has long supplemented national health budgets in LMICs, rising steadily and peaking in 2021 during the COVID-19 pandemic [3].
• Post-pandemic, the growth trend in DAH reversed sharply [3].
• In India, National Health Policy (NHP) 2017 set the benchmark of raising public health spending to 2.5–3% of GDP, a target reiterated by the Economic Survey 2020-21 [1].
• Government Health Expenditure (GHE) as a share of GDP rose from 1.13% (2014-15) to 1.84% (2021-22) per National Health Accounts (NHA) estimates [1].
• Share of government expenditure in Total Health Expenditure rose from 28.6% (FY14) to 40.6% (FY19), and further to 48% by FY22 per Economic Survey 2024-25 [1].

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic

• Fiscal contraction in donor countries directly translates into service delivery gaps in recipient LMICs, especially for HIV/TB/malaria and maternal-child health programmes historically aid-dependent [2].
• Domestic resource mobilisation (tax-financed health spending) becomes the only sustainable substitute as external aid shrinks [3].

Social

• Least Developed Countries and Sub-Saharan Africa face disproportionate cuts — bilateral ODA to LDCs may fall 13–25%, and to Sub-Saharan Africa 16–28% — worsening health equity for the most vulnerable [2].
• In India, reduced OOPE (out-of-pocket expenditure) is directly linked to rising government share of health spending; NHP 2017 envisaged OOPE falling from 65% to 35% of total spend as public spending rises [1].

Governance / Administrative

• The "spend better" argument stresses allocative and technical efficiency (targeting, reducing leakages, PFM reform) as an offset to reduced fiscal space, rather than only demanding higher outlays [3].
• Multilateral agencies like WHO face concentrated donor risk — 11 major donors account for 62% of WHO funding and 87% of WFP funding, per OECD data, creating institutional fragility [2].

Geopolitical / Strategic

• Simultaneous aid cuts by the US, UK, France and Germany signal a broader retrenchment of Western multilateralism in global health, with implications for pandemic preparedness and WHO's operational capacity [2].

6. Recent Developments (last 12–18 months)

• Early 2025: US announces 67% cut to foreign assistance programme, the single largest DAH contributor globally [3].
• 2025: UK, France, Germany announce cuts of 39%, 35%, 12% respectively [3].
• June 2025: OECD publishes "Cuts in Official Development Assistance" policy brief projecting 9–17% ODA decline for 2025 [2].
• 2025: WHO projects up to 40% reduction in global health aid for the year [2].
• Economic Survey 2024-25 (India): Reports government health expenditure share in Total Health Expenditure rose to 48% between FY15 and FY22 [1].
• Union Health Ministry: Released National Health Accounts Estimates for India 2022-23 [1].

7. Prelims Hooks

• India's Total Health Expenditure (2021-22): ₹9,04,461 crore, 3.83% of GDP [1].
• NHP 2017 target for public health spending: 2.5–3% of GDP [1].
• Government Health Expenditure as % of GDP rose from 1.13% (2014-15) to 1.84% (2021-22) [1].
• Share of government expenditure in Total Health Expenditure: 48% in FY22, up from 28.6% in FY14 [1].
• Centre : State split in Government Health Expenditure ≈ 35.7% : 64.3% [1].
• US historically contributes over one-third of global Development Assistance for Health [3].
• US announced 67% cut to foreign assistance in early 2025 [3].
• UK cut aid by 39%, France by 35%, Germany by 12% (2025) [3].
• DAH peaked in 2021 during COVID-19 [3].
• OECD projects 9–17% fall in net global ODA in 2025 [2].
• Bilateral ODA for health projected to fall 19–33% in 2025 vs 2023 [2].
• Health funding could fall up to 60% from its 2022 peak [2].
• WHO-projected health aid cut for 2025: up to 40% [2].
• LMIC–HIC health spending gap (% of GDP) narrowed from 2.05 to 1.68 percentage points, 2000–2023, but widened >3-fold in per-capita terms [3].
• Body publishing India's National Health Accounts: Ministry of Health & Family Welfare, not NITI Aayog [1].

8. Mains Relevance

• GS-II: Governance — "Issues relating to health"; government policies and interventions for development in health sector.
• GS-III: Indian Economy — public expenditure, fiscal federalism, budgeting.
• Possible question stems: 1. "Despite convergence in health spending as a share of GDP, the gap between LMICs and high-income countries has widened in absolute terms. Discuss with reference to global aid trends." (GS-II/III) 2. "Critically examine India's progress toward the National Health Policy 2017 target of 2.5–3% of GDP on public health spending." (GS-II) 3. "In an era of shrinking development assistance for health, is 'spending better' a more viable strategy than 'spending more' for LMICs? Discuss." (GS-III)

9. Related Topics to Study Next

• National Health Policy 2017 — sets India's own domestic spending benchmark referenced here.
• Ayushman Bharat / PM-JAY — flagship UHC-linked scheme testing public spending efficiency.
• National Health Accounts (NHA) methodology — how India measures health expenditure.
• 15th Finance Commission health sector recommendations — Centre-State fiscal transfers for health.
• WHO Pandemic Treaty / IHR amendments — multilateral health governance under funding stress.
• OECD DAC and ODA framework — how global aid flows are tracked and classified.
• SDG 3 (Good Health and Well-Being) — UHC financing targets at the global level.
• Out-of-Pocket Expenditure (OOPE) trends in India — the flip side of low public spending.

10. Common Errors / Trap Areas

• Confusing Total Health Expenditure (THE) with Government Health Expenditure (GHE) — India's GHE is 1.84% of GDP, not 3.83% (that is THE) [1].
• Assuming the LMIC–HIC health spending gap is closing overall — it is narrowing as % of GDP but widening in per-capita terms [3].
• Attributing India's National Health Accounts to NITI Aayog instead of the Ministry of Health & Family Welfare [1].
• Mixing up country-specific aid cut percentages: US 67%, UK 39%, France 35%, Germany 12% — commonly transposed in MCQs [3].
• Treating "Development Assistance for Health" (DAH) as identical to overall ODA — DAH is a health-specific subset tracked separately and cut more steeply than aggregate ODA [2][3].